Thermo Fisher Scientific Inc. Stock Borsa Italiana
Equities
4TMO
US8835561023
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
544 EUR | -0.87% | -0.55% | +12.89% |
Sales 2024 * | 43.02B 39.67B | Sales 2025 * | 46.1B 42.51B | Capitalization | 223B 206B |
---|---|---|---|---|---|
Net income 2024 * | 6.15B 5.67B | Net income 2025 * | 6.97B 6.43B | EV / Sales 2024 * | 5.73 x |
Net Debt 2024 * | 23.49B 21.66B | Net Debt 2025 * | 19.14B 17.65B | EV / Sales 2025 * | 5.25 x |
P/E ratio 2024 * |
36.7
x | P/E ratio 2025 * |
31.5
x | Employees | 122,000 |
Yield 2024 * |
0.26% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | -0.87% | ||
1 week | -0.55% | ||
Current month | +1.45% | ||
1 month | +1.68% | ||
3 months | +4.17% | ||
6 months | +21.56% | ||
Current year | +12.89% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-05-24 | 538 | -1.10% |
24-05-23 | 544 | -0.87% |
24-05-22 | 548.8 | +1.01% |
24-05-21 | 543.3 | -0.84% |
24-05-20 | 547.9 | +0.16% |
End-of-day quote Borsa Italiana, May 22, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B | |
+23.97% | 31.33B |
- Stock Market
- Equities
- TMO Stock
- 4TMO Stock